FX7-37058-27453
2 vaccinations
4 coded responses
6 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 118 / NY
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-02-27
Dose 2 — Pfizer-BioNTech
-
2021-03-11
Registered in v-safe
-
2021-03-11
Survey response — day 7, dose 2MedDRA: Back pain, Chest discomfort, Dyspnoea, Glassy eyes, Office visit, Pain — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): pressure in chest, pain when transitioning from sitting to laying down, lower back pain, shortness of breath, glossy eye · Healthcare visit (other): I went to my Primary Care DoctorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-13
Survey response — day 14, dose 2MedDRA: Chest discomfort, Fatigue, Glassy eyes, Office visit, Pyrexia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Pressure/tightness in chest, tiredness, glossy eyes, lowgrade fever 99.5 · Healthcare visit (other): In personMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Report sent to call center — day 14, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-20
-
2021-05-29
Survey response — 3 months, dose 2MedDRA: Cardiac disorder, Heart rate increased, Office visit — Feeling: GoodFree text: High heart rate, saw cardiologist and did echo which found slightly thicker than normal walls of my heart.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-28
- 2021-12-17
-
2022-02-28
Survey response — 12 months, dose 2MedDRA: Inflammatory marker increased, Optic neuritis, Papilloedema — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: 10 days post booster, optical neuritis/papiladema. Inflammation blood markers were elevated.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-03-03
-
2022-03-03
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech |
Call center
3 call center cases
3 successful
1 wait over 3 months for a first call
Free text
Release 5 — day 7, dose 2
Systemic reaction (other): pressure in chest, pain when transitioning from sitting to laying down, lower back pain, shortness of breath, glossy eye
Healthcare visit (other): I went to my Primary Care Doctor
Release 5 — day 14, dose 2
Symptoms: Pressure/tightness in chest, tiredness, glossy eyes, lowgrade fever 99.5
Healthcare visit (other): In person
Release 8 — 3 months, dose 2
Symptoms: High heart rate, saw cardiologist and did echo which found slightly thicker than normal walls of my heart.
Release 11 — 12 months, dose 2
Symptoms: 10 days post booster, optical neuritis/papiladema. Inflammation blood markers were elevated.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Cardiac disorder | ✓ | ✓ | ✓ |
| SD | Chest discomfort | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Glassy eyes | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Inflammatory marker increased | · | · | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Optic neuritis | · | · | ✓ |
| SD | Papilloedema | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Back pain | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Glassy eyes | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release